跳至主要内容
临床试验/NCT06382467
NCT06382467尚未招募4 期

Comparison of Remimazolam and Propofol Combination vs. Propofol in Intraoperative Neurophysiologic Monitoring: A Randomized Controlled Trial

Chung-Ang University Gwangmyeong Hospital0 个研究点目标入组 56 人开始时间: 2024年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
56
主要终点
Incidence of intraoperative hypotension

研究概览

简要总结

This study aims to compare total intravenous anesthetic agents: combined remimazolam and propofol vs. propofol monotherapy. The comparison parameters are intraoperative hypotension, patient's involuntary movement, neurophysiological monitoring quality, onset time, recovery time, and postoperative rescue anti-emetics requirements.

详细描述

This study hypothesizes that the combination regimen of remimazolam and propofol as total intravenous anesthesia in neurosurgical procedures requiring neurophysiological monitoring can reduce the incidence of hypotension compared to propofol monotherapy while providing comparable levels of neurophysiological monitoring and surgical conditions. With this hypothesis, the study aims to compare the frequency, severity, and duration of hypotension, frequency of patient movement, and appropriateness of neurophysiological monitoring between the combination therapy of remimazolam and propofol and propofol monotherapy in total intravenous anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 19 and above with planned neurosurgical procedures requiring neurophysiological monitoring, classified as American Society of Anesthesiologists (ASA) physical status classification 1, 2, or 3 in the United States.

排除标准

  • Patients who refuse to participate in the study.
  • Patients who are pregnant or lactating.
  • Patients with hypersensitivity to the investigational drugs or to soy, peanuts, or Dextran
  • Patients with acute narrow-angle glaucoma.
  • Patients with alcohol or drug dependence.
  • Patients with hepatic impairment classified as Child-Pugh class C.
  • Patients with lactose intolerance.
  • Patients requiring emergency surgery.

研究组 & 干预措施

Combination group

Experimental

Combination regimen (remimazolam plus propofol)

干预措施: Remimazolam besylate + propofol MCT (Drug)

Propofol group

Active Comparator

Propofol monotherapy

干预措施: Propofol MCT (Drug)

结局指标

主要结局

Incidence of intraoperative hypotension

时间窗: operation day - postoperative 1 day

mean arterial pressure \< 65mmHg

次要结局

  • scores of neurophysiologic monitoring quality(operation day - postoperative 1 day)
  • Amount and number of inotropic agents(operation day - postoperative 1 day)
  • Incidence of participants' intraoperative involuntary movement(operation day - postoperative 1 day)
  • onset time of study drugs(operation day - postoperative 1 day)
  • The administration number of rescue anti-emetic agents(operation day - postoperative 3 day)
  • Time-weighted average of intraoperative hypotension(operation day - postoperative 1 day)
  • recovery time of study drugs (remimazolam+propofol or propofol)(operation day - postoperative 1 day)

研究者

发起方
Chung-Ang University Gwangmyeong Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiwon Han

Assistant professor

Chung-Ang University Gwangmyeong Hospital

相似试验

Comparison of Remimazolam and Propofol Combination... | 临床试验